Xavier Bower on North Star Select: Liquid Biopsy Advancements for Cancer Treatment | OncoDaily

Описание: In this video of OncoDaily, Xavier Bower from BillionToOne discusses their North Star Select test, presented at ASCO. This liquid biopsy test analyzes circulating tumor DNA to identify mutations and guide treatment selection. The test demonstrated increased sensitivity compared to current assays, detecting more actionable mutations in a clinical trial of 200 patients. This advancement addresses the challenge of tumors with low cell-free DNA shedding, offering more accurate data for treatment decisions.

Abstract:- https://doi.org/10.1200/JCO.2024.42.1...

#LiquidBiopsy #CancerDiagnostics #NorthStarSelect #Oncology #PrecisionMedicine #CirculatingTumorDNA #BillionToOne #ASCO2024 #MolecularCounting #CancerTreatment #ClinicalTrials #TestSensitivity #GeneticMutations #OncologyResearch #ActionableMutations #CancerCare #DiagnosticInnovation #CellFreeDNA #CancerTesting #MedicalTechnology #Cancer

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”